Kidney Protection with the Radical Scavenger α1-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
出版年份 2021 全文链接
标题
Kidney Protection with the Radical Scavenger α1-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
作者
关键词
-
出版物
Antioxidants
Volume 10, Issue 8, Pages 1271
出版商
MDPI AG
发表日期
2021-08-11
DOI
10.3390/antiox10081271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
- (2021) Michael S Hofman et al. LANCET
- Radiation-induced kidney toxicity: molecular and cellular pathogenesis
- (2021) Richard Klaus et al. Radiation Oncology
- Structure, Functions, and Physiological Roles of the Lipocalin α1-Microglobulin (A1M)
- (2021) Jesper Bergwik et al. Frontiers in Physiology
- 177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging
- (2021) Amanda Kristiansson et al. Biomolecules
- Binding of the human antioxidation protein α1-microglobulin (A1M) to heparin and heparan sulfate. Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro
- (2021) Jesper Bergwik et al. Redox Biology
- Human radical scavenger α1-microglobulin protects against hemolysis in vitro and α1-microglobulin knockout mice exhibit a macrocytic anemia phenotype
- (2020) Amanda Kristiansson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Knockout of the radical scavenger α1-microglobulin in mice results in defective bikunin synthesis, endoplasmic reticulum stress and increased body weight
- (2020) Jesper Bergwik et al. FREE RADICAL BIOLOGY AND MEDICINE
- Examining Absorbed Doses of Indigenously Developed 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy
- (2020) Kamaldeep et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients
- (2020) Giovanni Paganelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- α1-Microglobulin (A1M) Protects Human Proximal Tubule Epithelial Cells from Heme-Induced Damage In Vitro
- (2020) Amanda Kristiansson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of α1-Microglobulin (A1M) in Erythropoiesis and Erythrocyte Homeostasis—Therapeutic Opportunities in Hemolytic Conditions
- (2020) Amanda Kristiansson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression, Purification and Initial Characterization of Functional α1-Microglobulin (A1M) in Nicotiana benthamiana
- (2020) Magnus L. R. Carlsson et al. Frontiers in Plant Science
- Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
- (2019) Anna Sarnelli et al. MOLECULES
- 177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney
- (2019) Jingjing Zhang et al. JOURNAL OF NUCLEAR MEDICINE
- rA1M is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumors
- (2019) Charlotte Andersson et al. JOURNAL OF NUCLEAR MEDICINE
- The heme and radical scavenger α1-microglobulin (A1M) confers early protection of the immature brain following preterm intraventricular hemorrhage
- (2019) Olga Romantsik et al. Journal of Neuroinflammation
- Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
- (2019) S. Rudisile et al. BMC CANCER
- 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT
- (2019) Astrid Gosewisch et al. EJNMMI Research
- Oxidative stress as a potential target in acute kidney injury
- (2019) Anamaria Magdalena Tomsa et al. PeerJ
- Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results
- (2019) Ambreen Khawar et al. EJNMMI Research
- Use of Amifostine for Cytoprotection during Radiation Therapy: A Review
- (2019) Maurice King et al. ONCOLOGY
- Protection of kidney function with human antioxidation protein α1-microglobulin (A1M) in a mouse 177Lu-DOTATATE radiation therapy model
- (2018) Amanda Kristiansson et al. ANTIOXIDANTS & REDOX SIGNALING
- rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury
- (2018) Bo Åkerström et al. ANTIOXIDANTS & REDOX SIGNALING
- Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics
- (2018) R. Yahyapour et al. Clinical & Translational Oncology
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
- (2018) Wenshan Lv et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Salivary gland toxicity of PSMA Radioligand Therapy: relevance and preventive strategies
- (2018) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for177Lu-Labeled PSMA Peptides
- (2018) Nusrat J. Begum et al. JOURNAL OF NUCLEAR MEDICINE
- Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis
- (2018) Christian H. Pfob et al. EJNMMI Research
- Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review
- (2018) Daphne Merel Valerie Huizing et al. EJNMMI Research
- Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
- (2018) Michela Del Prete et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and “whole body” tumor dosimetry with treatment outcomes
- (2018) John A Violet et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617
- (2017) Clemens Kratochwil et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
- (2017) Lorenza Scarpa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results
- (2017) Federica Matteucci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour
- (2017) Anna Yordanova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
- (2017) Anna Yordanova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
- (2017) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bystander signaling via oxidative metabolism
- (2017) Humaira Sawal et al. OncoTargets and Therapy
- The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
- (2017) Lisa Bodei et al. Journal of Thoracic Disease
- 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
- (2017) Christoph A. Umbricht et al. EJNMMI Research
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Structural and biochemical characterization of two heme binding sites on α 1 -microglobulin using site directed mutagenesis and molecular simulation
- (2016) Sigurbjörg Rutardottir et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
- (2016) Hendrik Bergsma et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
- (2016) Lars Budäus et al. EUROPEAN UROLOGY
- Two New Faces of Amifostine: Protector from DNA Damage in Normal Cells and Inhibitor of DNA Repair in Cancer Cells
- (2016) Michal Hofer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiation Dosimetry for 177 Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
- (2016) Shozo Okamoto et al. JOURNAL OF NUCLEAR MEDICINE
- German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
- (2016) Kambiz Rahbar et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
- (2016) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
- (2016) Steven P. Rowe et al. MOLECULAR IMAGING AND BIOLOGY
- Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer
- (2016) Wolfgang P. Fendler et al. Oncotarget
- The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
- (2015) Michael Goldstein et al. Annual Review of Medicine
- Acute kidney injury in cardiac surgery
- (2015) Alan M. Gaffney et al. Current Opinion in Anesthesiology
- Opportunities and challenges of radiotherapy for treating cancer
- (2015) Dörthe Schaue et al. Nature Reviews Clinical Oncology
- Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review
- (2015) Michael S Broder WORLD JOURNAL OF GASTROENTEROLOGY
- The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment
- (2014) Seyed Jalal Hosseinimehr Future Oncology
- Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
- (2014) Lakhmir S. Chawla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
- (2013) V. E. Zannella et al. CLINICAL CANCER RESEARCH
- Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The cysteine 34 residue of A1M/α1-microglobulin is essential for protection of irradiated cell cultures and reduction of carbonyl groups
- (2013) S. Rutardottir et al. FREE RADICAL RESEARCH
- Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
- (2013) Michelle R. Campbell et al. Oxidative Medicine and Cellular Longevity
- Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
- (2012) Gou Mizutani et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- The Radical-Binding Lipocalin A1M Binds to a Complex I Subunit and Protects Mitochondrial Structure and Function
- (2012) Magnus G. Olsson et al. ANTIOXIDANTS & REDOX SIGNALING
- The crystal structure of human α1-microglobulin reveals a potential haem-binding site
- (2012) Winfried Meining et al. BIOCHEMICAL JOURNAL
- Insertion of Heme b into the Structure of the Cys34-Carbamidomethylated Human Lipocalin α1-Microglobulin: Formation of a [(Heme)2(α1-Microglobulin)]3 Complex
- (2012) Judith F. Siebel et al. CHEMBIOCHEM
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nephrotoxicity profiles and threshold dose values for [177Lu]-DOTATATE in nude mice
- (2012) Johanna Svensson et al. NUCLEAR MEDICINE AND BIOLOGY
- Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
- (2012) B. N. Chorley et al. NUCLEIC ACIDS RESEARCH
- Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy
- (2012) Mohammed N Tantawy et al. BMC Nephrology
- Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
- (2011) Tohru Fukai et al. ANTIOXIDANTS & REDOX SIGNALING
- Up-Regulation of A1M/α1-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative Damage
- (2011) Magnus G. Olsson et al. PLoS One
- Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
- (2010) Edith Lubos et al. ANTIOXIDANTS & REDOX SIGNALING
- 21 years of Biologically Effective Dose
- (2010) J F Fowler BRITISH JOURNAL OF RADIOLOGY
- Bystander Cell Death and Stress Response is Inhibited by the Radical Scavenger α1-Microglobulin in Irradiated Cell Cultures
- (2010) Magnus G. Olsson et al. RADIATION RESEARCH
- Human catalase: looking for complete identity
- (2010) Madhur M. Goyal et al. Protein & Cell
- Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
- (2009) Edgar J. Rolleman et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- (2009) W. E. Bolch et al. JOURNAL OF NUCLEAR MEDICINE
- α1-Microglobulin chromophores are located to three lysine residues semiburied in the lipocalin pocket and associated with a novel lipophilic compound
- (2009) Tord Berggård et al. PROTEIN SCIENCE
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
- (2008) B. D. Lawenda et al. JNCI-Journal of the National Cancer Institute
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update Summary: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Journal of Oncology Practice
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search